Publicacións en colaboración con investigadores/as de Hospital Virgen del Camino (14)

2023

  1. Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype

    Journal of Pathology, Vol. 259, Núm. 1, pp. 103-114

2019

  1. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas

    Head and Neck, Vol. 41, Núm. 1, pp. 79-91

2017

  1. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1)

    Oral Oncology, Vol. 70, pp. 58-64

2016

  1. Prognostic factors of recurrence and survival in vulvar melanoma

    International Journal of Gynecological Cancer, Vol. 26, Núm. 7, pp. 1307-1312

  2. Recomendaciones CODEPEH 2014 para la detección precoz de la hipoacusia diferida

    Anales de Pediatria, Vol. 85, Núm. 4, pp. 215.e1-215.e6

2015

  1. Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

    European Urology, Vol. 68, Núm. 2, pp. 256-262

  2. Resultados oncológicos según el tipo de resección en el tratamiento del cáncer de recto

    Cirugia Espanola, Vol. 93, Núm. 4, pp. 229-235

  3. Sequential combination of mitomycin C plus bacillus calmette-guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: Final outcome of CUETO 93009, a randomized prospective trial

    European Urology, Vol. 67, Núm. 3, pp. 508-516

2014

  1. Multicenter study of outcome in relation to the type of resection in rectal cancer

    Diseases of the Colon and Rectum, Vol. 57, Núm. 7, pp. 811-822

2011

  1. The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: External validation of the EORTC risk tables

    European Urology, Vol. 60, Núm. 3, pp. 423-430

2010

  1. Minimally invasive lateral approach in total hip replacement: A prospective randomized study

    Revista Espanola de Cirugia Ortopedica y Traumatologia, Vol. 54, Núm. 1, pp. 27-33

  2. Minimally invasive subvastus approach: Improving the results of total knee arthroplasty: A prospective, randomized trial

    Clinical Orthopaedics and Related Research

2009

  1. Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

    Journal of Urology, Vol. 182, Núm. 5, pp. 2195-2203

2008

  1. Prognostic Factors in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

    European Urology, Vol. 53, Núm. 5, pp. 992-1002